Pharmacological validation of dihydrofolate reductase as a drug target in <i>Mycobacterium abscessus</i>.

Authors:
Aragaw WW; Negatu DA; Bungard CJ; Dartois VA; Marrouni AE and 4 more

Journal:
Antimicrob Agents Chemother

Publication Year: 2023

DOI:
10.1128/aac.00717-23

PMCID:
PMC10777855

PMID:
38018963

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Antimicrob Agents Chemother

Abbreviation: Antimicrob Agents Chemother

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of <i>Clost…
Bassères E; Eubank TA; Begum K and 6 more (2024) - Transparency Score: 3/6
Clofazimine as a substitute for rifampicin improves efficacy of <i>Mycobacterium avium</i> pulmonar…
Salillas S; Raaijmakers J; Aarnoutse RE and 8 more (2024) - Transparency Score: 3/6
Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthrax.
Hilliard JJ; Jakielaszek C; Mannino F and 10 more (2024) - Transparency Score: 3/6
Inhibition of <i>Pseudomonas aeruginosa</i> quorum sensing by chemical induction of the MexEF-oprN …
Kristensen R; Andersen JB; Rybtke M and 9 more (2024) - Transparency Score: 3/6
Limitations of antifungal prophylaxis in preventing invasive <i>Candida</i> surgical site infection…
Carugati M; Arif S; Yarrington ME and 8 more (2024) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"C.J.B., A.E.M., E.B.N., D.B.O., and R.W. are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA."

Evidence found in paper:

"Research reported in this work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI132374. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025